Literature DB >> 1321431

A dominant mutation in the Wilms tumor gene WT1 cooperates with the viral oncogene E1A in transformation of primary kidney cells.

D A Haber1, H T Timmers, J Pelletier, P A Sharp, D E Housman.   

Abstract

Wilms tumor is a pediatric kidney cancer that has been linked to the inactivation of a tumor-suppressor gene at chromosome locus 11p13. The WT1 gene, mapping to this locus, is developmentally regulated in the kidney and encodes a putative transcription factor that has been shown to be mutated in Wilms tumor specimens. We have suggested that one such altered product of the WT1 gene may be capable of trans-dominant suppression, since the mutated allele was found to be coexpressed with the wild-type allele in a sporadic Wilms tumor. We therefore tested the ability of this mutant WT1 allele, containing an in-frame deletion within the DNA-binding domain, to transform primary baby rat kidney cells. The mutant WT1 gene was found to cooperate with the adenoviral E1A gene in transforming baby rat kidney cells, as demonstrated by growth in soft agar and tumorigenicity in nude mice. The wild-type WT1 gene in all of its alternatively spliced forms neither suppressed E1A-induced focus formation nor cooperated with E1A. Our results indicate that impairment of DNA binding of the WT1 tumor-suppressor gene product can result in a dominant negative mutation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321431      PMCID: PMC402128          DOI: 10.1073/pnas.89.13.6010

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence.

Authors:  F J Rauscher; J F Morris; O E Tournay; D M Cook; T Curran
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

2.  Genetic mechanisms of tumor suppression by the human p53 gene.

Authors:  P L Chen; Y M Chen; R Bookstein; W H Lee
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

3.  An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor.

Authors:  D A Haber; A J Buckler; T Glaser; K M Call; J Pelletier; R L Sohn; E C Douglass; D E Housman
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

4.  Mutation and cancer: a model for Wilms' tumor of the kidney.

Authors:  A G Knudson; L C Strong
Journal:  J Natl Cancer Inst       Date:  1972-02       Impact factor: 13.506

Review 5.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

6.  Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus.

Authors:  K M Call; T Glaser; C Y Ito; A J Buckler; J Pelletier; D A Haber; E A Rose; A Kral; H Yeger; W H Lewis
Journal:  Cell       Date:  1990-02-09       Impact factor: 41.582

7.  Evidence for WT1 as a Wilms tumor (WT) gene: intragenic germinal deletion in bilateral WT.

Authors:  V Huff; H Miwa; D A Haber; K M Call; D Housman; L C Strong; G F Saunders
Journal:  Am J Hum Genet       Date:  1991-05       Impact factor: 11.025

8.  Suppression of human colorectal carcinoma cell growth by wild-type p53.

Authors:  S J Baker; S Markowitz; E R Fearon; J K Willson; B Vogelstein
Journal:  Science       Date:  1990-08-24       Impact factor: 47.728

9.  Alternative splicing and genomic structure of the Wilms tumor gene WT1.

Authors:  D A Haber; R L Sohn; A J Buckler; J Pelletier; K M Call; D E Housman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

10.  WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour.

Authors:  J Pelletier; W Bruening; F P Li; D A Haber; T Glaser; D E Housman
Journal:  Nature       Date:  1991-10-03       Impact factor: 49.962

View more
  13 in total

1.  WT1 mutations in T-ALL.

Authors:  Valeria Tosello; Marc R Mansour; Kelly Barnes; Maddalena Paganin; Maria Luisa Sulis; Sarah Jenkinson; Christopher G Allen; Rosemary E Gale; David C Linch; Teresa Palomero; Pedro Real; Vundavalli Murty; Xiaopan Yao; Susan M Richards; Anthony Goldstone; Jacob Rowe; Giuseppe Basso; Peter H Wiernik; Elisabeth Paietta; Rob Pieters; Martin Horstmann; Jules P P Meijerink; Adolfo A Ferrando
Journal:  Blood       Date:  2009-06-03       Impact factor: 22.113

2.  DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1.

Authors:  I A Drummond; H D Rupprecht; P Rohwer-Nutter; J M Lopez-Guisa; S L Madden; F J Rauscher; V P Sukhatme
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

3.  Truncated WT1 mutants alter the subnuclear localization of the wild-type protein.

Authors:  C Englert; M Vidal; S Maheswaran; Y Ge; R M Ezzell; K J Isselbacher; D A Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

4.  Physical and functional interaction between WT1 and p53 proteins.

Authors:  S Maheswaran; S Park; A Bernard; J F Morris; F J Rauscher; D E Hill; D A Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

5.  A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome.

Authors:  C E Patek; M H Little; S Fleming; C Miles; J P Charlieu; A R Clarke; K Miyagawa; S Christie; J Doig; D J Harrison; D J Porteous; A J Brookes; M L Hooper; N D Hastie
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

Review 6.  Tumour suppressor gene mutations in humans and mice: parallels and contrasts.

Authors:  M L Hooper
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

7.  Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor.

Authors:  W L Gerald; J Rosai; M Ladanyi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

8.  Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product.

Authors:  H Nakagama; G Heinrich; J Pelletier; D E Housman
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

9.  Expression of a truncated Brca1 protein delays lactational mammary development in transgenic mice.

Authors:  Melissa A Brown; Hans Nicolai; Kathy Howe; Toyomasa Katagiri; El-Nasir Lalani; Kaylene J Simpson; Nathan W Manning; Andrew Deans; Phil Chen; Kum Kum Khanna; Mas Rina Wati; Beatrice L Griffiths; Chun-Fang Xu; Gordon W H Stamp; Ellen Solomon
Journal:  Transgenic Res       Date:  2002-10       Impact factor: 2.788

10.  WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis.

Authors:  C Englert; X Hou; S Maheswaran; P Bennett; C Ngwu; G G Re; A J Garvin; M R Rosner; D A Haber
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.